Pharmaceuticals, Biotechnology and Life Sciences
Accomplished biotechnology CEO brings 25 years of strategic, operational, and legal experienceFOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) —…
PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day” This event, organized in…
– Acoramidis demonstrated the earliest known time to separation in cardiovascular outcomes in the ATTRibute-CM study (3 months), with statistically…
Ben Austin, SPR Therapeutics Ben Austin, Chief Financial Officer and Chief Operating Officer of SPR Therapeutics. CLEVELAND, Nov. 18, 2024…
SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) — Siren Biotechnology, pioneer of AAV immuno-gene therapy for cancer, today revealed its…
Data demonstrate potential superiority of a targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4 targets…
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence of disease stabilization or improvement after a one-time…
SHANGHAI, Nov. 16, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) — Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), announced…
WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the “Company” or “Eagle”)…